Here’s the scary thing about diabetes: Over 30 million Americans have it, with an additional 1.4 million new diagnoses each year. The disease is the seventh-highest cause of death in the U.S.
Those are concerning statistics, but there are also some numbers that provide hope. Over 170 new medicines are currently in development targeting treatment of diabetes and diabetes-related conditions. Here are three of the most promising diabetes drugs from five of the most innovative drugmakers in the world: Merck, Pfizer, Lexicon Pharmaceuticals, Sanofi, and Novo Nordisk .
